![Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study]()
Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 StudyEngert, A.; Diehl, V.; Franklin, J.; Lohri, A.; Dorken, B.; Ludwig, W.-D.; Koch, P.; Hanel, M.; Pfreundschuh, M.; Wilhelm, M.; Trumper, L.; Aulitzky, W.-E.; Bentz, M.; Rummel, M.; Sezer, O.; Muller-Hermelink, H.-K.; Hasenclever, D.; Loffler, M. · Journal of Clinical Oncology · 2009